De GrootCJBergersEKamphorstWet al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions. Brain2001; 124(Pt. 8): 1635–1645.
2.
SormaniMPBruzziP.MRI lesions as a surrogate for relapses in multiple sclerosis: A meta-analysis of randomised trials. Lancet Neurol2013; 12(7): 669–676.
3.
MatthewsPMRabinerIGunnR.Non-invasive imaging in experimental medicine for drug development. Curr Opin Pharmacol2011; 11(5): 501–507.
4.
MatthewsPMJezzardP.Functional magnetic resonance imaging. J Neurol Neurosurg Psychiatry2004; 75(1): 6–12.
5.
KimJHBuddeMDLiangHFet al. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis2006; 21(3): 626–632.
6.
MatthewsPMHampshireA.Clinical concepts emerging from fMRI functional connectomics. Neuron2016; 91(3): 511–528.
7.
LeeMReddyHJohansen-BergHet al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neurol2000; 47(5): 606–613.
8.
LarvieMFischlB.Volumetric and fiber-tracing MRI methods for gray and white matter. Handb Clin Neurol2016; 135: 39–60.
9.
TomassiniVMatthewsPMThompsonAJet al. Neuroplasticity and functional recovery in multiple sclerosis. Nat Rev Neurol2012; 8(11): 635–646.
10.
DouaudGMenkeRAGassAet al. Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer’s disease. J Neurosci2013; 33(5): 2147–2155.
